PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Why now
Thesis: Routine compensation filing with no material signal
Catalyst to watch: None identifiable from the text
Main risk: Minor shareholder dilution from option grants
Why it matters
Routine inducement grants under Nasdaq rules are standard compensation disclosures with minimal market signal.
Details
WARREN, N.J., Sept. 25, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Sept. 22, 2026, the company approved non-statutory stock options to purchase an aggregate of 51,270 shares of its common stock and 37,995 restricted stock units ("RSUs"), each...
Sources
- prnewswire · 2026-09-25 20:30 UTC